G. Evin

C. Masters, K. Beyreuther, R. Cappai, 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

γ-secretase modulators: hopes and setbacks for the future of Alzheimer’s treatment

G. Evin, 2008, Expert review of neurotherapeutics.

Alternative transcripts of presenilin‐1 associated with frontotemporal dementia

C. Masters, K. Beyreuther, R. Cappai, 2002, Neuroreport.

Levels of [3H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1

B. Dean, G. Evin, E. Scarr, 2008, Schizophrenia Research.

Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease.

C. Masters, K. Beyreuther, G. Evin, 2001, Biochemistry.

A crossreactive antipeptide monoclonal antibody with specificity for lysyl-lysine

G. Evin, L. Khachigian, F. J. Morgan, 1991 .

Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.

C. Masters, G. Evin, M. F. Sernee, 2006, CNS drugs.

In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.

G. Evin, P. Corvol, D. Nisato, 1985, Journal of cardiovascular pharmacology.

[Conditions for the use of specific antibodies for immunohistochemical visualization of serotonin and melatonin in the pineal gland of sheep].

G. Evin, Y. Tillet, M. Dubois, 1986, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Peptide Coupling Reagents; VIII. A High Yield Preparation of Phenyl Esters of Amino Acids using Benzotriazolyloxytris[dimethylamino]phosphonium Hexafluorophosphate (BOP Reagent)

G. Evin, R. Seyer, B. Castro, 1977 .

Peptide Coupling Reagents VI1. A Novel, Cheaper Preparation of Benzotriazolyloxytris[dimethylamino]phosphonium Hexafluorophosphate (BOP Reagent)

G. Evin, B. Castro, J. Dormoy, 1976 .

Mild Oxidative Stress Induces Redistribution of BACE1 in Non-Apoptotic Conditions and Promotes the Amyloidogenic Processing of Alzheimer’s Disease Amyloid Precursor Protein

G. Ciccotosto, P. Crouch, G. Evin, 2013, PloS one.

Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets.

K. Beyreuther, G. Evin, C. Masters, 1998, Laboratory investigation; a journal of technical methods and pathology.

Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.

C. Masters, D. Small, K. Beyreuther, 1995, Biochemistry.

Inhibition of γ-Secretase as a Therapeutic Intervention for Alzheimer’s Disease

C. Masters, G. Evin, M. F. Sernee, 2006 .

Pharmacological knock-down of the presenilin 1 heterodimer by a novel gamma -secretase inhibitor: implications for presenilin biology.

C. Masters, A. Nadin, G. Evin, 2001, The Journal of biological chemistry.

Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue

A. Harvey, R. Martins, G. Evin, 2001, Neuroscience.

Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and β-amyloid precursor protein

K. Beyreuther, G. Evin, C. Masters, 1997, Nature Medicine.

Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors

G. Evin, 2016, BioDrugs.

Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer’s disease

G. Evin, A. Barakat, 2014, Degenerative neurological and neuromuscular disease.

BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status

G. Evin, Genevieve Evin, Christopher Hince, 2013, Drugs & Aging.

Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia

B. Dean, G. Evin, E. Scarr, 2010, Schizophrenia Research.

Soluble pepstatins: a new approach to blockade in vivo of the renin-angiotensin system.

J. Ménard, G. Evin, P. Corvol, 1978, Clinical science and molecular medicine. Supplement.

Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets

Colin L Masters, C. Masters, G. Evin, 2003, Journal of neuroscience research.

Alzheimer's disease amyloid precursor protein (ApPP): proteolytic processing, secretases and βA4 amyloid production

C. Masters, K. Beyreuther, G. Evin, 1994 .

Platelets and Alzheimer's disease: Potential of APP as a biomarker.

G. Evin, Qiao-Xin Li, 2012, World journal of psychiatry.

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity*

C. Masters, A. Hill, A. Bush, 2006, Journal of Biological Chemistry.

β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis

G. Evin, Jiangli Tan, 2012, Journal of neurochemistry.

Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues

A. Hill, A. Bush, G. Evin, 2011, Clinical science.

Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity.

M. Freeman, A. Hill, G. Evin, 2011, Journal of Alzheimer's disease : JAD.

Modulation of amyloid precursor protein processing by synthetic ceramide analogues.

A. Hill, G. Evin, Hongyun Li, 2010, Biochimica et biophysica acta.

The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation.

C. Masters, K. Beyreuther, G. Evin, 2004, The Journal of biological chemistry.

Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides

G. Evin, A. Weidemann, 2002, Peptides.

Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex.

C. Masters, B. Dean, R. Cappai, 2004, Brain research. Molecular brain research.

Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

C. Masters, K. Beyreuther, G. Evin, 2002, Annals of neurology.

Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein

C. Masters, A. Hill, S. Bellingham, 2011, Neurobiology of Disease.

Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease

C. Masters, K. Beyreuther, G. Evin, 2002 .

Altered Amyloid-β Metabolism and Deposition in Genomic-based β-Secretase Transgenic Mice*

S. Younkin, L. Younkin, G. Evin, 2004, Journal of Biological Chemistry.

A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing.

C. Masters, K. Beyreuther, G. Evin, 2002, Biochemistry.

Paradoxical Condensation of Copper with Elevated β-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions

C. Masters, A. Bush, R. Cherny, 2009, The Journal of Biological Chemistry.

Synthesis and Renin Inhibitory Properties of a New Soluble Pepstatin Derivative

J. Ménard, G. Evin, P. Corvol, 1980, Journal of cardiovascular pharmacology.

In vitro gamma‐secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc

C. Masters, G. Evin, D. Hoke, 2005, The FEBS journal.

Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease.

Christopher C Rowe, Colin L Masters, Victor L Villemagne, 2011, Journal of Alzheimer's disease : JAD.

BACE inhibitors as potential therapeutics for Alzheimer's disease.

G. Evin, V. Kenche, 2007, Recent patents on CNS drug discovery.

Increased β‐Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects

C. Masters, G. Evin, R. Holsinger, 2004, Annals of neurology.

Synthesis of peptides related to the prosegment of mouse submaxillary gland renin precursor: an approach to renin inhibitors.

J. Ménard, G. Evin, P. Corvol, 1984, Proceedings of the National Academy of Sciences of the United States of America.

p75NTR Regulates Aβ Deposition by Increasing Aβ Production But Inhibiting Aβ Aggregation with Its Extracellular Domain

C. Masters, G. Evin, Qiao-Xin Li, 2011, The Journal of Neuroscience.

New renin inhibitors homologous with pepstatin.

J. Ménard, G. Evin, P. Corvol, 1981, The Biochemical journal.

A novel metalloprotease in rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments.

C. Masters, D. Small, K. Beyreuther, 1997, Biochemistry.

Chemical approach of synthetic immunogens from human renin.

J. Michel, G. Evin, R. Seyer, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Characterization of five epitopes of human renin from a computer model.

J. Ménard, J. Novotný, M. Handschumacher, 1988, Biochemistry.

Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.

S. Younkin, L. Younkin, G. Evin, 2004, The Journal of biological chemistry.

Alternative transcripts of presenilin-1 associated with frontotemporal dementia.

C. Masters, K. Beyreuther, R. Cappai, 2002, NeuroReport.

BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity.

G. Evin, G. Lessene, S. Wilkins, 2011, Recent patents on CNS drug discovery.

Correction: Mild Oxidative Stress Induces Redistribution of BACE1 in Non-Apoptotic Conditions and Promotes the Amyloidogenic Processing of Alzheimer’s Disease Amyloid Precursor Protein

G. Ciccotosto, P. Crouch, G. Evin, 2013, PLoS ONE.

Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors

G. Evin, 2016, BioDrugs.

A domain level interaction network of amyloid precursor protein and Aβ of Alzheimer's disease

N. Faux, C. Masters, H. Hermjakob, 2010, Proteomics.

PEPTIDE COUPLING REAGENTS. VI. A NOVEL, CHEAPER PREPARATION OF BENZOTRIAZOLYLOXYTRIS(DIMETHYLAMINO)PHOSPHONIUM HEXAFLUOROPHOSPHATE (BOP REAGENT)

G. Evin, B. Castro, J. Dormoy, 1977 .

Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias

C. Masters, K. Beyreuther, G. Evin, 2002, Annals of neurology.

Degenerative Neurological and Neuromuscular Disease Dovepress Critical Analysis of the Use of Β-site Amyloid Precursor Protein-cleaving Enzyme 1 Inhibitors in the Treatment of Alzheimer's Disease

G. Evin, A. Barakat, 2022 .

Study of the Antigenic Determinants of Human Renin

J. Novotný, M. Handschumacher, E. Haber, 1986, Hypertension.